Keritrina Overview

  • Status
  • Acquired/​Merged

  • Latest Deal Type
  • Asset Purch.

  • Financing Rounds
  • 1

Keritrina General Information

Description

A generic cardio drug product. The drug Keritrina contains the active pharmaceutical ingredient nitroglycerin which is used for the treatment of heart disease.

Contact Information

Ownership Status
Acquired/Merged
Financing Status
Corporate Backed or Acquired
Primary Industry
Buildings and Property
Other Industries
Pharmaceuticals
Primary Office
  • Via Filanda, 5
  • Gessate
  • 20060 Milan
  • Italy

Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Keritrina Valuation & Funding

Deal Type Date Amount Valuation/
EBITDA
Post-Val Status Debt

This information is available in the PitchBook Platform. To explore Keritrina‘s full profile, request access.

Request a free trial

Keritrina Former Investors

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info

This information is available in the PitchBook Platform. To explore Keritrina‘s full profile, request access.

Request a free trial